PCI-CLARITY: is clopidogrel pretreatment before PCI beneficial?
Hannah Camm
This article has no abstract so we have provided the first paragraph of the full text.
Following percutaneous coronary intervention (PCI), antiplatelet therapy in the form of aspirin alone or dual therapy with aspirin and clopidogrel can lower the risk of adverse thrombotic and ischemic events. Whether treatment with clopidogrel before PCI prevents more complications than clopidogrel administered at the time of PCI in patients with ST-segment elevation myocardial infarction (STEMI) who have received fibrinolytic therapy is, however, unclear.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
